IQVIA HOLDINGS INC (QTS.DE) Stock Fundamental Analysis

FRA:QTS • US46266C1053

133.95 EUR
-16.9 (-11.2%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

QTS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 21 industry peers in the Life Sciences Tools & Services industry. While QTS is still in line with the averages on profitability rating, there are concerns on its financial health. QTS is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • QTS had positive earnings in the past year.
  • QTS had a positive operating cash flow in the past year.
  • QTS had positive earnings in 4 of the past 5 years.
  • QTS had a positive operating cash flow in 4 of the past 5 years.
QTS.DE Yearly Net Income VS EBIT VS OCF VS FCFQTS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • The Return On Assets of QTS (4.47%) is comparable to the rest of the industry.
  • QTS has a better Return On Equity (20.83%) than 95.24% of its industry peers.
  • With a decent Return On Invested Capital value of 9.77%, QTS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • QTS had an Average Return On Invested Capital over the past 3 years of 8.99%. This is in line with the industry average of 10.06%.
  • The last Return On Invested Capital (9.77%) for QTS is above the 3 year average (8.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.47%
ROE 20.83%
ROIC 9.77%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
QTS.DE Yearly ROA, ROE, ROICQTS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.07%, QTS is in line with its industry, outperforming 52.38% of the companies in the same industry.
  • In the last couple of years the Profit Margin of QTS has grown nicely.
  • QTS has a Operating Margin (14.20%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of QTS has grown nicely.
  • Looking at the Gross Margin, with a value of 33.78%, QTS is doing worse than 61.90% of the companies in the same industry.
  • In the last couple of years the Gross Margin of QTS has remained more or less at the same level.
Industry RankSector Rank
OM 14.2%
PM (TTM) 8.07%
GM 33.78%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
QTS.DE Yearly Profit, Operating, Gross MarginsQTS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QTS is destroying value.
  • QTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QTS.DE Yearly Shares OutstandingQTS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QTS.DE Yearly Total Debt VS Total AssetsQTS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 1.76, we must say that QTS is in the distress zone and has some risk of bankruptcy.
  • QTS's Altman-Z score of 1.76 is on the low side compared to the rest of the industry. QTS is outperformed by 71.43% of its industry peers.
  • QTS has a debt to FCF ratio of 6.76. This is a slightly negative value and a sign of low solvency as QTS would need 6.76 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 6.76, QTS perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
  • A Debt/Equity ratio of 2.08 is on the high side and indicates that QTS has dependencies on debt financing.
  • The Debt to Equity ratio of QTS (2.08) is worse than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF 6.76
Altman-Z 1.76
ROIC/WACC0.94
WACC10.43%
QTS.DE Yearly LT Debt VS Equity VS FCFQTS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • QTS has a Current Ratio of 0.70. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of QTS (0.70) is worse than 85.71% of its industry peers.
  • QTS has a Quick Ratio of 0.70. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of QTS (0.70) is worse than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
QTS.DE Yearly Current Assets VS Current LiabilitesQTS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • QTS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.09%.
  • Measured over the past years, QTS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.19% on average per year.
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.26%

3.2 Future

  • Based on estimates for the next years, QTS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.58% on average per year.
  • QTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.57% yearly.
EPS Next Y9.67%
EPS Next 2Y10.17%
EPS Next 3Y10.4%
EPS Next 5Y11.58%
Revenue Next Year5.44%
Revenue Next 2Y5.61%
Revenue Next 3Y5.72%
Revenue Next 5Y6.57%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
QTS.DE Yearly Revenue VS EstimatesQTS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
QTS.DE Yearly EPS VS EstimatesQTS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.33, QTS is valued correctly.
  • 90.48% of the companies in the same industry are more expensive than QTS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.67. QTS is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 12.16, which indicates a correct valuation of QTS.
  • Based on the Price/Forward Earnings ratio, QTS is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of QTS to the average of the S&P500 Index (27.69), we can say QTS is valued rather cheaply.
Industry RankSector Rank
PE 13.33
Fwd PE 12.16
QTS.DE Price Earnings VS Forward Price EarningsQTS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QTS indicates a somewhat cheap valuation: QTS is cheaper than 76.19% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of QTS indicates a rather cheap valuation: QTS is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.25
EV/EBITDA 11.78
QTS.DE Per share dataQTS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • QTS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.38
PEG (5Y)1.01
EPS Next 2Y10.17%
EPS Next 3Y10.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for QTS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IQVIA HOLDINGS INC

FRA:QTS (2/12/2026, 7:00:00 PM)

133.95

-16.9 (-11.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-04
Inst Owners100.57%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner ChangeN/A
Market Cap22.81B
Revenue(TTM)N/A
Net Income(TTM)1.28B
Analysts83.45
Price Target223.17 (66.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.2%
Min EPS beat(2)-0.04%
Max EPS beat(2)0.45%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)12
Avg EPS beat(16)1.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)6
Avg Revenue beat(16)-0.16%
PT rev (1m)4.37%
PT rev (3m)18.85%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)0.09%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.33
Fwd PE 12.16
P/S 1.7
P/FCF 12.25
P/OCF 9.66
P/B 4.4
P/tB N/A
EV/EBITDA 11.78
EPS(TTM)10.05
EY7.5%
EPS(NY)11.02
Fwd EY8.23%
FCF(TTM)10.93
FCFY8.16%
OCF(TTM)13.87
OCFY10.35%
SpS78.65
BVpS30.46
TBVpS-71.68
PEG (NY)1.38
PEG (5Y)1.01
Graham Number83
Profitability
Industry RankSector Rank
ROA 4.47%
ROE 20.83%
ROCE 11.17%
ROIC 9.77%
ROICexc 10.83%
ROICexgc N/A
OM 14.2%
PM (TTM) 8.07%
GM 33.78%
FCFM 13.9%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.08
Debt/FCF 6.76
Debt/EBITDA 3.78
Cap/Depr 52.48%
Cap/Sales 3.73%
Interest Coverage 250
Cash Conversion 82.76%
Profit Quality 172.33%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 1.76
F-Score5
WACC10.43%
ROIC/WACC0.94
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
EPS Next Y9.67%
EPS Next 2Y10.17%
EPS Next 3Y10.4%
EPS Next 5Y11.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.26%
Revenue Next Year5.44%
Revenue Next 2Y5.61%
Revenue Next 3Y5.72%
Revenue Next 5Y6.57%
EBIT growth 1Y4.3%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.34%
EBIT Next 3Y11.04%
EBIT Next 5Y9.71%
FCF growth 1Y67.37%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y42.92%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%

IQVIA HOLDINGS INC / QTS.DE FAQ

What is the ChartMill fundamental rating of IQVIA HOLDINGS INC (QTS.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE.


What is the valuation status for QTS stock?

ChartMill assigns a valuation rating of 7 / 10 to IQVIA HOLDINGS INC (QTS.DE). This can be considered as Undervalued.


What is the profitability of QTS stock?

IQVIA HOLDINGS INC (QTS.DE) has a profitability rating of 6 / 10.


How financially healthy is IQVIA HOLDINGS INC?

The financial health rating of IQVIA HOLDINGS INC (QTS.DE) is 1 / 10.


Is the dividend of IQVIA HOLDINGS INC sustainable?

The dividend rating of IQVIA HOLDINGS INC (QTS.DE) is 0 / 10 and the dividend payout ratio is 0%.